Hutchinson Capital Management CA Has $14.55 Million Stock Holdings in Waters Co. (NYSE:WAT)

Hutchinson Capital Management CA boosted its position in Waters Co. (NYSE:WAT) by 41.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,157 shares of the medical instruments supplier’s stock after buying an additional 14,631 shares during the period. Waters makes up approximately 3.0% of Hutchinson Capital Management CA’s portfolio, making the stock its 11th biggest position. Hutchinson Capital Management CA owned approximately 0.08% of Waters worth $14,552,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in WAT. Andra AP fonden grew its holdings in Waters by 16.8% during the second quarter. Andra AP fonden now owns 45,940 shares of the medical instruments supplier’s stock worth $13,328,000 after buying an additional 6,600 shares in the last quarter. Royal London Asset Management Ltd. boosted its holdings in Waters by 0.6% during the 2nd quarter. Royal London Asset Management Ltd. now owns 22,968 shares of the medical instruments supplier’s stock worth $6,663,000 after acquiring an additional 128 shares during the last quarter. LGT Group Foundation grew its stake in shares of Waters by 14.7% in the 2nd quarter. LGT Group Foundation now owns 59,334 shares of the medical instruments supplier’s stock worth $17,214,000 after acquiring an additional 7,606 shares in the last quarter. Choreo LLC raised its holdings in shares of Waters by 22.4% in the second quarter. Choreo LLC now owns 1,912 shares of the medical instruments supplier’s stock valued at $539,000 after purchasing an additional 350 shares during the last quarter. Finally, Prudential PLC lifted its position in shares of Waters by 61.3% during the second quarter. Prudential PLC now owns 27,212 shares of the medical instruments supplier’s stock valued at $7,895,000 after purchasing an additional 10,340 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on WAT. Leerink Partners raised shares of Waters from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $325.00 to $375.00 in a research report on Thursday, August 1st. Wells Fargo & Company assumed coverage on Waters in a report on Tuesday, August 27th. They issued an “overweight” rating and a $380.00 target price for the company. Deutsche Bank Aktiengesellschaft dropped their price target on Waters from $330.00 to $310.00 and set a “hold” rating on the stock in a report on Thursday, August 1st. Jefferies Financial Group began coverage on Waters in a research note on Monday, June 3rd. They issued a “hold” rating and a $320.00 price objective for the company. Finally, The Goldman Sachs Group raised shares of Waters to a “hold” rating in a report on Wednesday, July 31st. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $318.50.

Waters Stock Up 1.0 %

WAT opened at $332.08 on Tuesday. The company has a 50 day moving average of $322.44 and a 200 day moving average of $324.80. The company has a current ratio of 2.10, a quick ratio of 1.42 and a debt-to-equity ratio of 1.42. Waters Co. has a 12 month low of $231.90 and a 12 month high of $367.21. The company has a market cap of $19.71 billion, a PE ratio of 32.59, a price-to-earnings-growth ratio of 5.70 and a beta of 0.95.

Waters (NYSE:WAT) last announced its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $2.63 earnings per share for the quarter, beating the consensus estimate of $2.55 by $0.08. The company had revenue of $709.00 million during the quarter, compared to analysts’ expectations of $700.09 million. Waters had a return on equity of 56.81% and a net margin of 20.71%. The firm’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same period in the previous year, the business earned $2.80 earnings per share. On average, sell-side analysts expect that Waters Co. will post 11.6 EPS for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.